The Supreme Court's interpretation of the biosimilars statute and the value of certainty

Nature Biotechnology 35, 916 (2017). doi:10.1038/nbt.3977 Authors: Irena Royzman & Nathan Monroe-Yavneh The Supreme Court's decision in Sandoz v. Amgen introduces uncertainty into provisions that many viewed as necessary and enforceable, but its impact may ultimately be modest.
Source: Nature Biotechnology - Category: Biotechnology Authors: Tags: Feature Source Type: research